Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ronald Scott

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 8, 2006
The genetic tyrosinemiasC Ronald Scott
American Journal of Hematology|June 23, 2015
Long-term treatment outcomes in Gaucher diseaseJoel Charrow, C Ronald Scott
Journal of Zhejiang University. Science. B|January 20, 2006
Human biochemical genetics: an insight into inborn errors of metabolismChunli Yu, C Ronald Scott
JIMD Reports|June 27, 2019
Validation of a therapeutic range for nitisinone in patients treated for tyrosinemia type 1 based on reduction of succinylacetone excretionRhona M Jack, C Ronald Scott
Blood Cells, Molecules & Diseases|September 28, 2005
Hematologically important mutations: Gaucher diseaseErnest Beutler, Terri Gelbart, C Ronald Scott
Pediatrics|November 23, 2017
Newborn Screening for Pompe DiseaseOlaf A Bodamer, C Ronald Scott, Roberto Giugliani, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 2, 2019
Response to Neeleman et alJeffrey M Chinsky, Can Ficicioglu, C Ronald Scott
Clinical Chemistry|December 6, 2014
Newborn screening for lysosomal storage diseasesMichael H Gelb, C Ronald Scott, Frantisek Turecek
Methods in Molecular Biology (Clifton, N.J.)|May 9, 2007
Tandem mass spectrometry in the detection of inborn errors of metabolism for newborn screeningFrantisek Turecek, C Ronald Scott, Michael H Gelb
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 8, 2017
Molecular pathogenicity of novel sucrase-isomaltase mutations found in congenital sucrase-isomaltase deficiency patientsBirthe Gericke, Mahdi Amiri, C Ronald Scott, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 8, 2006
The genetic tyrosinemiasC Ronald Scott
American Journal of Hematology|June 23, 2015
Long-term treatment outcomes in Gaucher diseaseJoel Charrow, C Ronald Scott
Journal of Zhejiang University. Science. B|January 20, 2006
Human biochemical genetics: an insight into inborn errors of metabolismChunli Yu, C Ronald Scott
JIMD Reports|June 27, 2019
Validation of a therapeutic range for nitisinone in patients treated for tyrosinemia type 1 based on reduction of succinylacetone excretionRhona M Jack, C Ronald Scott
Blood Cells, Molecules & Diseases|September 28, 2005
Hematologically important mutations: Gaucher diseaseErnest Beutler, Terri Gelbart, C Ronald Scott
Pediatrics|November 23, 2017
Newborn Screening for Pompe DiseaseOlaf A Bodamer, C Ronald Scott, Roberto Giugliani, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 2, 2019
Response to Neeleman et alJeffrey M Chinsky, Can Ficicioglu, C Ronald Scott
Clinical Chemistry|December 6, 2014
Newborn screening for lysosomal storage diseasesMichael H Gelb, C Ronald Scott, Frantisek Turecek
Methods in Molecular Biology (Clifton, N.J.)|May 9, 2007
Tandem mass spectrometry in the detection of inborn errors of metabolism for newborn screeningFrantisek Turecek, C Ronald Scott, Michael H Gelb
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 8, 2017
Molecular pathogenicity of novel sucrase-isomaltase mutations found in congenital sucrase-isomaltase deficiency patientsBirthe Gericke, Mahdi Amiri, C Ronald Scott, et al.
Pageof 9